Skip to content

Aspen Aerogels ASPN Free cash flow

Free cash flow at other companies

Cabot Corporation logo
Cabot CorporationCBT
$32M+3,100%
QuantumScape Corporation
 logo
QuantumScape Corporation QS
-$69.49M-4.4%
Owens Corning logo
Owens CorningOC
EnerSys logo
EnerSysENS
Fluor logo
FluorFLR
BorgWarner logo
BorgWarnerBWA

Other financials

Income statement

See full
Revenue$37.9M-51.9%
Gross profit$4.3M-81.3%
Operating income-$20.8M+93.0%
Net income-$23.7M+92.1%
EPS (diluted)-$0.29+92.1%

Balance sheet

See full
Cash & equivalents$173.9M-9.5%
Total debt$113.4M-18.8%
Total equity$213.5M-32.2%
Total assets$410.5M-26.0%

Cash flow

See full
Operating cash flow$34.1M+506%
CapEx$1.4M-89.5%

Valuation

See full
Market cap$470.74M-1.1%
Enterprise value$410.28M-3.1%
P/S+1.0×

Profitability

See full
Gross margin32.9%-7.1pp
Operating margin-43.3%-8.2pp
Net margin-48.6%-9.9pp
FCF margin-22.3%-10.1pp

Returns & leverage

See full
Return on equity-42.4%-12.2pp
Debt / equity0.5×+0.1×
Current ratio2.9×-1.3×

Where this comes from

Calculated from Aspen Aerogels’s reported figures.

The official record: Aspen Aerogels’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aspen Aerogels's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aspen Aerogels's free cash flow?
Aspen Aerogels (ASPN) reported free cash flow of $32.78M in Q1 2026.
How has Aspen Aerogels's free cash flow changed year-over-year?
Aspen Aerogels's free cash flow increased by 545.0% year-over-year, from -$7.37M to $32.78M.
What is the long-term trend for Aspen Aerogels's free cash flow?
Over 2 years (2021 to 2023), Aspen Aerogels's free cash flow has grown at a 159.4% compound annual growth rate (CAGR), from -$32.41M to -$218.07M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.